title: Port site metastasis after laparoscopy for uterine cervical carcinoma.
abstract: BACKGROUND
  Aim of this study was to review cases reported of port-site recurrence (PSR) after laparoscopy for uterine cervical carcinoma.
  
  
  METHODS
  A Medline computer database search from January 1980 to September 2002.
  
  
  RESULTS
  We reported 13 cases published of PSR after laparoscopy for cervical carcinoma. The majority of them were squamous carcinoma (9/13 at least, 69%) and initial staging of disease was Ib (7/13 (54%)). Median of interval between laparoscopy and diagnostic of PSR was 7 months (min 1.5 month, max 48 months). Of 10 cases of laparoscopy with lymphadenectomy, in three cases (30%) nodes were not involved. PSR developed at the port through which tissues was extracted in four cases (30.1%) or another port in five cases (38.5%). At the time of PSR, five patients (38.5%) were free of disease.
  
  
  CONCLUSIONS
  PSR were reported after laparoscopy for lymphadenenectomy with or without hysterectomy and with or without node involvement. In some cases, umbilical metastases should not be systematically diagnosed as PSR and a diagnosis of Sister Mary Joseph's nodule may be discussed.
authors.affiliation: Department of Obstetrics and Gynecology, La Conception Hospital, 147 Bd Baille, Marseille 13005, France. aagostini@mail.ap-hm.fr
authors.forename: A
authors.initials: A
authors.lastname: Agostini
authors.forename: X
authors.initials: X
authors.lastname: Carcopino
authors.forename: F
authors.initials: F
authors.lastname: Franchi
authors.forename: L
authors.initials: L
authors.lastname: Cravello
authors.forename: F
authors.initials: F
authors.lastname: Lécuru
authors.forename: B
authors.initials: B
authors.lastname: Blanc
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D001706:Biopsy / Q000009:adverse effects; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000556:secondary* / Q000601:surgery*; D002408:Catheters, Indwelling; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects; D010535:Laparoscopy / Q000009:adverse effects*; D008197:Lymph Node Excision / Q000009:adverse effects; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local; D009366:Neoplasm Seeding; D009367:Neoplasm Staging; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery*